Stand-Alone Part D Plans Greatly Increased Use of Coinsurance, Tying Patient Costs of Often Inflated List Prices (IMAGE)
Caption
Expected out-of-pocket costs for many brand name drugs have surged amid rising rebates and discounts to middlemen.
Credit
USC Schaeffer Center for Health Policy & Economics
Usage Restrictions
Please credit
License
Original content